Information  X 
Enter a valid email address

OPG Power Ventures (OPG)

  Print      Mail a friend

Tuesday 20 November, 2018

OPG Power Ventures

Result of Scrip Dividend and Issue of Equity

RNS Number : 9494H
OPG Power Ventures plc
20 November 2018
 

20 November 2018

 

OPG Power Ventures plc

("OPG", the "Group" or the "Company")

Result of Scrip Dividend and Issue of Equity

Further to the Company's previous announcements, OPG announces that it has received valid elections for the Scrip Dividend in respect of 356,308,697 existing ordinary shares of 0.0147 pence each in the capital of the Company ("Ordinary Shares").

Accordingly, based on the previously announced reference price of 11.275 pence per share and the final dividend of 1 pence per share, a total of 31,601,503 new Ordinary Shares will be allotted by the Company to shareholders.

Application has been made to AIM for the new Ordinary Shares to be admitted to trading on AIM ("Admission").  Admission of the new Ordinary Shares is expected on 3 December 2018 ("Admission").  It is expected that the new Ordinary Shares will be issued and credited to CREST accounts on 3 December 2018.

Following Admission, the Company will have 387,910,200 Ordinary Shares in issue admitted to trading on AIM and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

For further information, please visit www.opgpower.com or contact:

OPG Power Ventures PLC

+91 (0) 44 429 11211

Arvind Gupta / Dmitri Tsvetkov



Cenkos Securities (Nominated Adviser & Broker)

+44 (0) 20 7397 8900

Stephen Keys



Tavistock (Financial PR)

+44 (0) 20 7920 3150

Simon Hudson / Barney Hayward

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCFKKDQPBDDBDB

a d v e r t i s e m e n t